InMode Ltd. (NASDAQ:INMD) Q2 2022 Earnings Conference Call July 28, 2022 8:30 AM ET

Company Participants

Miri Segal - Investor Relations, MS-IR LLC

Moshe Mizrahy - Chairman and Chief Executive Officer

Michael Kreindel - Chief Technology Officer & Director

Yair Malca - Chief Financial Officer

Shakil Lakhani - President, North America

Spero Theodorou - Chief Medical Officer

Rafael Lickerman - VP of Finance

Conference Call Participants

Q - Joseph Conway

Q - Jeff Johnson

Operator

Good morning and welcome to the InMode Ltd. Second Quarter 2022 Earnings Result Conference Call. All participants will be in a listen-only mode. [Operator instructions]. Please note this event is being recorded.

I would now like to turn the conference over to Miri Segal, CEO of MS-IR. Please go ahead.

Miri Segal

Thank you, operator, and to everyone for joining us today. Welcome to InMode's second quarter 2022 earnings call. Before we begin, I would like to remind our listeners that certain information provided on this call may contain forward-looking statements, and the Safe Harbor statement outlined in today's earnings release also pertains to this call. If you have not received a copy of the release, please visit the Investor Relations section of the company's website.

Changes in business, competitive, technological, regulatory, and other factors could cause actual results to differ materially from those expressed by the forward-looking statements made today. Our historical results are not necessarily indicative of future performance. As such, we can give no assurance as to the accuracy of our forward-looking statements and assume no obligation to update them except as required by law.

With that, I'd like to turn the call over to Moshe Mizrahy, Chairman and CEO. Moshe please go ahead.

Moshe Mizrahy

Thank you, Miri. And thanks to everyone joining us for our second quarter 2022 earnings call. With me today Dr. Michael Kreindel, our Co-Founder and Chief Technology Officer; Yair Malca, our Chief Financial Officer; Shakil Lakhani, our President in North America; Dr. Spero Theodorou, our Chief Medical Officer; and Rafael Lickerman our VP of Finance. Following our prepared remarks, we will be all be available for a Q&A session.

We are pleased to report another record quarter with revenue of $113.5 million, an increase of 30% compared to the same period last year. Clearly, growth across the U.S. and the key region globally underscored the strong demand for our technologies and our product portfolio. Our growth engine include the launch of two new modality every year growth in the United States, geographical expansion outside the U.S. and high volume sales of consumable as a result of more frequent use of our platforms. All these factors remain on track and support continued successful execution in the second half of 2022 and beyond.